Rilzabrutinib, also known as PRN1008, is a reversible covalent, selective and oral active inhibitor of Brutons Tyrosine Kinase (BTK) with IC50 of 1.3 nM.
Molecular Weight:
665.76
Purity:
>98%
CAS Number:
[1575596-29-0]
Formula:
C36H40FN9O3
Target:
BTK
* VAT and and shipping costs not included. Errors and price changes excepted
